Cogent Biosciences, Inc.
Profit History
| Period | Revenue | Operating Income | Net Income |
|---|---|---|---|
| Mar 2017 | $1.8M | $-6.1M | $-5.9M |
| Jun 2017 | $2.1M | $-6.0M | $-5.9M |
| Sep 2017 | $2.3M | $-7.2M | $-7.0M |
| Dec 2017 | $2.1M | $-6.9M | $-6.7M |
| Mar 2018 | $2.2M | $-7.0M | $-6.7M |
| Jun 2018 | $1.7M | $-9.4M | $-9.0M |
| Sep 2018 | $2.0M | $-10.6M | $-10.2M |
| Dec 2018 | $3.8M | $-9.0M | $-8.6M |
| Mar 2019 | $3.1M | $-11.8M | $-11.7M |
| Jun 2019 | $3.1M | $-10.5M | $-10.5M |
| Sep 2019 | $1.0M | $-12.0M | $-11.9M |
| Dec 2019 | $15.3M | $2.2M | $2.3M |
| Mar 2020 | $7.0M | $-6.1M | $-6.1M |
| Jun 2020 | $528.0K | $-7.4M | $-7.4M |
| Sep 2020 | $312.0K | $-57.2M | $-50.0M |
| Dec 2020 | $0 | $-11.5M | $-11.3M |
| Mar 2021 | — | $-12.8M | $-11.7M |
| Jun 2021 | — | $-17.3M | $-16.5M |
| Sep 2021 | — | $-19.8M | $-19.1M |
| Dec 2021 | — | $-25.6M | $-24.9M |
| Mar 2022 | — | $-31.4M | $-30.6M |
| Jun 2022 | — | $-35.9M | $-34.9M |
| Sep 2022 | — | $-36.8M | $-35.1M |
| Dec 2022 | — | $-43.7M | $-39.6M |
| Mar 2023 | — | $-43.2M | $-38.6M |
| Jun 2023 | — | $-47.1M | $-44.1M |
| Sep 2023 | — | $-59.6M | $-55.4M |
| Dec 2023 | — | $-58.2M | $-54.4M |
| Mar 2024 | — | $-62.4M | $-58.3M |
| Jun 2024 | — | $-64.4M | $-59.0M |
| Sep 2024 | — | $-75.4M | $-70.6M |
| Dec 2024 | — | $-73.7M | $-67.9M |
| Mar 2025 | — | $-74.9M | $-72.0M |
| Jun 2025 | — | $-75.6M | $-73.5M |
| Sep 2025 | — | $-83.4M | $-80.9M |
| Dec 2025 | — | $-99.5M | $-102.5M |
| Mar 2026 | — | $-103.6M | $-97.4M |
| Jun 2026 | — | $-102.6M | $-96.4M |